Kimia Biosciences has announced a board meeting to consider the financial results for the quarter and half-year.

The company has also informed shareholders about an Extraordinary General Meeting (EGM) to be conducted through video conferencing at its corporate office, with e-voting facilities provided for member participation.

This update ensures shareholders can engage in key decision-making processes remotely, reflecting the company’s adherence to digital governance practices and enhancing shareholder convenience.